Workflow
SI-BONE(SIBN) - 2025 Q1 - Earnings Call Transcript
2025-05-05 21:32
SI-BONE (SIBN) Q1 2025 Earnings Call May 05, 2025 04:30 PM ET Company Participants Saqib Iqbal - Senior Director of FP&A and Investor RelationsLaura Francis - Chief Executive OfficerAnshul Maheshwari - Chief Financial OfficerPhillip Dantoin - Assistant Vice PresidentYoung Li - Senior VP - Equity ResearchCaitlin Cronin - Director Conference Call Participants Craig Bijou - Equity Research AnalystDavid Turkaly - Research AnalystDavid Saxon - Senior AnalystRavi Misra - Associate Analyst - Medtech Equity Researc ...
Offerpad Solutions (OPAD) - 2025 Q1 - Earnings Call Transcript
2025-05-05 21:32
Offerpad Solutions (OPAD) Q1 2025 Earnings Call May 05, 2025 04:30 PM ET Company Participants Cortney Read - Chief of Staff & VP, OperationsBrian Bair - Founder, Chairman & CEOPeter Knag - Chief Financial OfficerNicholas Jones - MD - Internet Equity ResearchDae Lee - VP - Equity ResearchRyan Tomasello - Managing DirectorMichael Ng - Managing Director - Global Investment ResearchVincent Kardos - Senior Associate Operator Good afternoon, and thank you for attending today's Offerpad First Quarter twenty twenty ...
Matson(MATX) - 2025 Q1 - Earnings Call Transcript
2025-05-05 21:32
Matson (MATX) Q1 2025 Earnings Call May 05, 2025 04:30 PM ET Company Participants Justin Schoenberg - Director, Investor Relations & Corporate DevelopmentMatthew Cox - Chairman, Director & CEOJoel M. Wine - Executive VP & CFODaniel Imbro - Managing DirectorOmar Nokta - Managing DirectorBenjamin Nolan - Managing Director Conference Call Participants Jacob Lacks - Analyst Operator you for standing by and welcome to Matson's First Quarter twenty twenty five Financial Results Conference Call. At this time, all ...
Ichor (ICHR) - 2025 Q1 - Earnings Call Transcript
2025-05-05 21:32
Financial Data and Key Metrics Changes - First quarter revenues were $244.5 million, up 5% sequentially from Q4 and 21% year-over-year [5][20] - Gross margin for Q1 was 12.4%, an increase of 40 basis points from Q4 but below the forecast of 14.5% [20] - Operating income for Q1 was $6.6 million, with net interest expense at $1.6 million and non-GAAP net income tax expense at $600,000 [20] Business Line Data and Key Metrics Changes - The company acknowledged challenges in transitioning from externally sourced products to internally manufactured products, impacting gross margins [6][20] - A new contract in the commercial space market led to higher costs and revenue push-outs due to redesign requirements [9] - The decision to exit the refurbishment business in Scotland had a slight negative impact on both revenue and gross margin [9] Market Data and Key Metrics Changes - The overall customer demand environment has remained consistent, with expectations for modest growth in wafer fab equipment (WFE) for 2025 [5] - Specific markets such as silicon carbide applications have weakened, affecting OEM customers differently [15] Company Strategy and Development Direction - The company aims to increase the use of proprietary, internally sourced components to drive gross margin expansion [10][17] - By the end of 2025, the company expects to have all four major customers qualified on all three major product families [12] - Planned capital expenditures for 2025 are expected to be around 4% of revenue, higher than the historical average of 2% [21] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the strategy despite recent challenges, indicating that improvements in gross margins are expected as internal supply ramps up [18] - The company anticipates Q2 revenues between $225 million and $245 million, reflecting a slight decrease in visibility compared to previous guidance [15][22] - Management noted that geopolitical uncertainties and tariff impacts could affect future demand but did not foresee significant demand erosion [91] Other Important Information - The company is working to mitigate the impact of tariffs on gross margins and is collaborating with customers to manage costs [40][41] - The exit from the refurbishment business in Scotland was primarily due to declining demand, with an estimated annual revenue loss of around $10 million [99] Q&A Session Summary Question: Change in revenue outlook for the year - Management indicated that the softer outlook is primarily due to a slowdown in the lithography business and challenges in the non-semi business [26][28] Question: Execution on gross margin internalization - Management estimated that they achieved about 75% to 80% of their internal sourcing goals in Q1, with ongoing improvements expected [30][32] Question: Impact of tariffs on customers - Management noted that while some customers are pushing costs down, the company is working collaboratively to manage tariff impacts [40][41] Question: Confidence in second half growth - Management expressed confidence in continued strength in DRAM and NAND investments, with expectations for growth in the second half [46][91] Question: Disconnect with largest customer's guidance - Management clarified that they do not see significant disconnects in outlooks, with expectations for semi business to strengthen in the second half [54] Question: Clarification on severance costs - The majority of severance costs were related to exiting the Scotland operation, with some smaller reductions also accounted for [65]
EverQuote(EVER) - 2025 Q1 - Earnings Call Transcript
2025-05-05 21:32
EverQuote (EVER) Q1 2025 Earnings Call May 05, 2025 04:30 PM ET Company Participants Brinlea Johnson - Managing Partner and Co-Head of East CoastJayme Mendal - CEOJoseph Sanborn - Chief Financial OfficerJed Kelly - Managing Director - Equity Research Conference Call Participants Maria Ripps - Managing Director, Senior Research AnalystJason Kreyer - Senior Research AnalystZach Cummins - Senior Research AnalystRalph Schackart - Equity Research AnalystMayank Tandon - Senior AnalystNone - Analyst Operator Good ...
Ekso Bionics(EKSO) - 2025 Q1 - Earnings Call Transcript
2025-05-05 21:32
Ekso Bionics (EKSO) Q1 2025 Earnings Call May 05, 2025 04:30 PM ET Company Participants Stephen Kilmer - Investor RelationsJerome Wong - Chief Financial OfficerScott Davis - Chief Executive OfficerBen Haynor - Managing Director Conference Call Participants Swayampakula Ramakanth - Managing Director & Senior Equity Analyst Operator Greetings, and welcome to the Ekso Bionics First Quarter twenty twenty five Financial Results Conference Call. At this time, all participants are in a listen only mode. A question ...
Ekso Bionics(EKSO) - 2025 Q1 - Earnings Call Transcript
2025-05-05 21:32
Ekso Bionics (EKSO) Q1 2025 Earnings Call May 05, 2025 04:30 PM ET Company Participants Stephen Kilmer - Investor RelationsJerome Wong - Chief Financial OfficerScott Davis - Chief Executive OfficerBen Haynor - Managing Director Conference Call Participants Swayampakula Ramakanth - Managing Director & Senior Equity Analyst Operator Greetings, and welcome to the Ekso Bionics First Quarter twenty twenty five Financial Results Conference Call. At this time, all participants are in a listen only mode. A question ...
Denny’s(DENN) - 2025 Q1 - Earnings Call Transcript
2025-05-05 21:32
Denny's (DENN) Q1 2025 Earnings Call May 05, 2025 04:30 PM ET Company Participants Kayla Money - Senior Director - Enterprise FP&A & Investor RelationsKelli Valade - Chief Executive OfficerRobert Verostek - EVP and CFOJon Tower - Director & Equity Research - Consumer & RestaurantsAllison Arfstrom - Equity Research Associate Conference Call Participants Michael Tamas - Director & Senior AnalystJake Bartlett - Senior Equity Research AnalystTodd Brooks - Equity Research AnalystEric Gonzalez - Senior Research A ...
Castle Biosciences(CSTL) - 2025 Q1 - Earnings Call Transcript
2025-05-05 21:32
Castle Biosciences (CSTL) Q1 2025 Earnings Call May 05, 2025 04:30 PM ET Company Participants Camilla Zuckero - Vice President of Investor Relations & Corporate AffairsDerek Maetzold - Founder, President & CEOMatthew Goldberg - Senior Vice President of MedicalFrank Stokes - CFOPuneet Souda - Senior MDTom Peterson - Senior Research AssociatePaul Knight - Managing DirectorSubbu Nambi - Managing Director Conference Call Participants Sung Ji Nam - Managing Director, Senior Equity Research AnalystKyle Mikson - M ...
Artivion(AORT) - 2025 Q1 - Earnings Call Transcript
2025-05-05 21:32
Artivion (AORT) Q1 2025 Earnings Call May 05, 2025 04:30 PM ET Company Participants Laine Morgan - Associate Vice PresidentPatrick Mackin - Chairman , President & CEOLance Berry - Executive VP & CFOJohn McAulay - AVPSuraj Kalia - Managing DirectorDaniel Stauder - Director - Equity ResearchJeffrey Cohen - MD - Equity Research Conference Call Participants Frank Takkinen - Senior Research AnalystMichael Matson - Senior Analyst Operator Greetings. Welcome to our Ativian's First Quarter twenty twenty five Financ ...